We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$2.7B
AUM Growth
-$320M
Cap. Flow
-$307M
Cap. Flow %
-11.35%
Top 10 Hldgs %
22.03%
Holding
131
New
4
Increased
13
Reduced
110
Closed
4

Top Buys

Rank Stock Value
1
AXTA icon
Axalta
AXTA
+$20.9M
2
COLD icon
Americold
COLD
+$15.1M
3
HXL icon
Hexcel
HXL
+$14.6M
4
AMTM
Amentum Holdings
AMTM
+$11.1M
5
TROX icon
Tronox
TROX
+$6.36M

Sector Composition

Rank Sector Weight
1 Industrials 25.22%
2 Technology 19.37%
3 Healthcare 14.85%
4 Financials 14.08%
5 Consumer Discretionary 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURN icon
1
Huron Consulting
HURN
$2.71B
$72.5M 2.69%
583,732
-54,532
-9% -$6.39M
MTSI icon
2
MACOM Technology Solutions
MTSI
$17.4B
$66.3M 2.45%
510,010
-57,140
-10% -$7.19M
MMSI icon
3
Merit Medical Systems
MMSI
$4.82B
$63.7M 2.36%
658,785
-87,878
-12% -$8.76M
AER icon
4
AerCap
AER
$23.4B
$63.5M 2.35%
663,154
-88,474
-12% -$8.49M
ITRI icon
5
Itron
ITRI
$4.48B
$60.9M 2.26%
560,938
-71,697
-11% -$8.01M
ACIW icon
6
ACI Worldwide
ACIW
$6.12B
$58.9M 2.18%
1,133,999
-128,690
-10% -$6.84M
DY icon
7
Dycom Industries
DY
$11.2B
$55.4M 2.05%
318,106
-40,493
-11% -$7.49M
HQY icon
8
HealthEquity
HQY
$8.71B
$55M 2.04%
573,441
+35,128
+7% +$3.27M
SUM
9
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$49.4M 1.83%
976,737
-106,493
-10% -$4.98M
BDC icon
10
Belden
BDC
$3.97B
$49.2M 1.82%
436,498
-48,781
-10% -$5.82M
AEIS icon
11
Advanced Energy
AEIS
$10.1B
$49.1M 1.82%
424,501
-46,656
-10% -$5.25M
TKO icon
12
TKO Group
TKO
$14B
$46.8M 1.73%
329,372
-56,087
-15% -$7.32M
GTLS
13
DELISTED
Chart Industries
GTLS
$46.2M 1.71%
242,147
-10,123
-4% -$1.63M
PBH icon
14
Prestige Consumer Healthcare
PBH
$2.47B
$45.6M 1.69%
583,474
-64,071
-10% -$4.97M
AZEK
15
DELISTED
The AZEK Co
AZEK
$45.4M 1.68%
956,121
-108,734
-10% -$5.19M
NBHC icon
16
National Bank Holdings
NBHC
$1.9B
$43M 1.59%
998,245
-110,367
-10% -$5M
CHE icon
17
Chemed
CHE
$7.16B
$41.5M 1.54%
78,393
-9,038
-10% -$5.09M
B
18
DELISTED
Barnes Group Inc.
B
$40.3M 1.49%
852,204
-93,015
-10% -$4.32M
KN icon
19
Knowles
KN
$2.95B
$40.1M 1.49%
2,012,986
-217,577
-10% -$4.05M
SUPN icon
20
Supernus Pharmaceuticals
SUPN
$2.7B
$38.9M 1.44%
1,075,868
-118,358
-10% -$4.17M
EFOR
21
Everforth Inc
EFOR
$960M
$38.1M 1.41%
456,990
-51,994
-10% -$4.75M
BOX icon
22
Box
BOX
$4.49B
$37.8M 1.4%
1,195,813
-130,514
-10% -$4.28M
EEFT icon
23
Euronet Worldwide
EEFT
$3.19B
$37.1M 1.37%
360,878
+824
+0.2% +$83.9K
HASI icon
24
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$36.6M 1.36%
1,365,822
-5,326
-0.4% -$167K
KBR icon
25
KBR
KBR
$4.56B
$34.7M 1.29%
598,901
-23,693
-4% -$1.51M

Similar funds

Aristotle Capital Boston's Q4 2024 Portfolio in Review

As of Q4 2024, Aristotle Capital Boston held 131 positions worth $2.7B, down 11% from $3.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aristotle Capital Boston withdrew a net $307M in Q4 2024, closing 4 positions and reducing 110 holdings. Its most notable exit was Aspen Technology Inc, an estimated $30M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in Axalta worth $19M.

  • Aristotle Capital Boston's largest Q4 2024 buy was Axalta: 555,240 shares worth $19M.
  • Aristotle Capital Boston added most to Amentum Holdings in Q4 2024, an estimated $11.1M increase.
  • Aristotle Capital Boston's biggest Q4 2024 reduction was Baldwin Insurance Group, cutting an estimated $34.9M.
  • Aristotle Capital Boston fully exited Aspen Technology Inc in Q4 2024, selling an estimated $30M.
  • Aristotle Capital Boston's ten largest holdings make up 22% of its $2.7B portfolio in Q4 2024.
  • Aristotle Capital Boston opened 4 new positions and closed 4 in Q4 2024.
  • Aristotle Capital Boston's portfolio value fell 11% quarter-over-quarter to $2.7B.

Based on Aristotle Capital Boston's 13F filing for Q4 2024, filed 14 Feb 2025.